India Drug Delivery Devices Market Forecast & Opportunities, FY2026: Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch) & Route of Administration (Oral Drug Delivery, Injectable Drug Delivery) – ResearchAndMarkets.com

India Drug Delivery Devices Market Forecast & Opportunities, FY2026: Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch) & Route of Administration (Oral Drug Delivery, Injectable Drug Delivery) – ResearchAndMarkets.com




India Drug Delivery Devices Market Forecast & Opportunities, FY2026: Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch) & Route of Administration (Oral Drug Delivery, Injectable Drug Delivery) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “India Drug Delivery Devices Market, By Devices (Syringe, Inhaler, Nebulizer, Transdermal Patch), By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Others), By Patient Care Setting, By Application, By Region, By Region, Forecast & Opportunities, FY2026” report has been added to ResearchAndMarkets.com’s offering.

The Indian Drug Delivery Devices Market was valued at around USD564 million in FY2020 and is expected to grow at a steady CAGR of 8.05% during the forecast period.

The Indian Drug Delivery Devices Market is driven by growing use of drug delivery systems in healthcare facilities. Growing awareness regarding drug metabolism is expected to propel the market growth through FY2026. In addition to this, increasing pervasiveness of chronic infections among the population is further anticipated to bolster the growth of the Indian Drug Delivery Devices Market in a positive way.

With COVID-19 infections rising, the apprehension regarding a shortage of essential life-saving devices and other essential medical supplies to prevent the spread of this pandemic and provide optimum care to the infected also widens, which is anticipated to fuel the market growth over the coming years.

The Indian Drug Delivery Devices Market is segmented based on devices, route of administration, patient care setting, application, company, and region. Considering the patient care setting, the market is fragmented into hospitals, diagnostic centres, ambulatory surgery centres, and others.

Among these, the hospitals segment dominated the Indian Drug Delivery Devices Market until FY2020 and is further anticipated to maintain its dominance during the forecast period as well. This high growth can be attributed to the significant number of inpatient and outpatient visits to hospitals and requirement of large volumes of drugs and their respective delivery devices to accommodate to the demand of the large patient pool.

Major players operating in the Indian Drug Delivery Devices Market include Pfizer Limited, Novartis India Limited, India Medtronic Private Limited, GlaxoSmithKline Pharmaceuticals Limited, Cardinal Health India Private Limited, B. Braun Medical India Private Limited, Sun Pharmaceutical Industries Limited., 3M India Limited, Cipla Limited, Bayer Pharmaceuticals India Ltd and others.

The market players are adopting some competitive strategies such as technological developments, mergers & acquisitions, partnership, collaborations, agreements to expand their geographic reach and to increase their customer bases.

Key Target Audience:

  • Drug delivery devices manufacturers, suppliers, distributors, and other stakeholders
  • Government bodies such as regulating authorities and policy makers.
  • Organizations, forums, and alliances related to drug delivery devices.
  • Market research and consulting firms

Years considered for this report:

  • Historical Years: FY2016-FY2019
  • Base Year: FY2020
  • Estimated Year: FY2021
  • Forecast Period: FY2022-FY2026

Key Topics Covered:

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 of India Drug Delivery Devices Market

4. Executive Summary

5. Voice of Customer/Customer Insight

6. India Drug Delivery Devices Market Outlook

7. India Drug Delivery Devices Market Outlook

7.1. Market Size & Forecast

7.1.1. By Value

7.2. Market Share & Forecast

7.2.1. By Device (Syringes, Inhalers, Nebulizer, Transdermal Patches)

7.2.2. By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Others)

7.2.3. By Patient Care Setting (Hospitals, Diagnostic Centres, Ambulatory Surgery Centres, Others)

7.2.4. By Application (Cancer, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Others)

7.2.5. By Region (East, West, North, South)

7.2.6. By Company

7.3. Market Attractiveness Index

8. India Syringe Drug Delivery Market Outlook

8.1. Market Size & Forecast

8.1.1. By Value

8.2. Market Share & Forecast

8.2.1. By Type (Conventional, Pre-filled, Safety)

8.2.2. By Patient Care Setting

8.2.3. By Application

9. India Inhaler Drug Delivery Market Outlook

9.1. Market Size & Forecast

9.1.1. By Value

9.2. Market Share & Forecast

9.2.1. By Type (Metered dose inhaler, Dry powder inhaler)

9.2.2. By Patient Care Setting

9.2.3. By Application

10. India Nebulizer Drug Delivery Market Outlook

10.1. Market Size & Forecast

10.1.1. By Value

10.2. Market Share & Forecast

10.2.1. By Type (Jet, Ultrasonic, Mesh)

10.2.2. By Patient Care Setting

10.2.3. By Application

11. India Transdermal Patch Drug Delivery Market Outlook

11.1. Market Size & Forecast

11.1.1. By Value

11.2. Market Share & Forecast

11.2.1. By Type (Single-layer Drug-in-Adhesive, Multi-layer Drug-in-Adhesive, Others

11.2.2. By Patient Care Setting

11.2.3. By Application

12. Market Dynamics

12.1. Drivers

12.2. Challenges

13. Market Trends & Developments

14. Policy and Regulatory Landscape

15. India Economic Profile

16. Competitive Landscape

16.1. Company Profiles

16.1.1. Pfizer Limited

16.1.2. Novartis India Limited

16.1.3. India Medtronic Private Limited

16.1.4. GlaxoSmithKline Pharmaceuticals Limited

16.1.5. Cardinal Health India Private Limited

16.1.6. B. Braun Medical India Private Limited

16.1.7. Sun Pharmaceutical Industries Limited

16.1.8. 3M India Limited

16.1.9. Cipla Limited

16.1.10. Bayer Pharmaceuticals India Ltd.

17. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/rhiw7d

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900